Literature DB >> 6347179

Metabolism of 3-deoxy-3-fluoro-D-mannose and 4-deoxy-4-fluoro-D-mannose by Saccharomyces cerevisiae S288C.

T J Grier, J R Rasmussen.   

Abstract

Incubation of Saccharomyces cerevisiae S288C with 4-deoxy-4-fluoro-D-[1-14C]-mannose resulted in the formation of three metabolites that were characterized as 4-deoxy-4-fluoro-D-[1-14C]mannose 1,6-bisphosphate, 4-deoxy-4-fluoro-D-[1-14C]-mannose 6-phosphate and GDP-4-deoxy-4-fluoro-D-[1-14C]mannose. In addition, radioactive material was incorporated into a particulate fraction composed primarily of cell-wall polysaccharides. Compared with the 4-fluoro sugar, 3-deoxy-3-fluoro-D-[1-14C]mannose was not transported into yeast cells as well, and its conversion into sugar nucleotide was much less efficient. Metabolites that were isolated after incubation with the 3-fluoro analogue were identified as 3-deoxy-3-fluoro-D-[1-14C]mannose 1,6-bisphosphate, 3-deoxy-3-fluoro-D-[1-14C]mannose 6-phosphate and GDP-3-deoxy-3-fluoro-D-[1-14C]mannose. Little radioactivity was transferred into the cell-wall fraction.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6347179      PMCID: PMC1154145          DOI: 10.1042/bj2090677

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

2.  Formation of uridine diphosphate 2-deoxy-D-glucose and guanosine diphosphate 2-deoxy-D-glucose in vitro using animal enzymes.

Authors:  R T Schwarz; F G Schmidt
Journal:  Eur J Biochem       Date:  1976-02-02

3.  Nucleoside-diphosphate derivatives of 2-deoxy-D-glucose in animal cells.

Authors:  M F Schmidt; R T Schwarz; C Scholtissek
Journal:  Eur J Biochem       Date:  1974-11-01

4.  Some in vivo and in vitro antitumour effects of the deoxyfluoro-D-glucopyranoses.

Authors:  E M Bessell; V D Courtenay; A B Foster; M Jones; J H Westwood
Journal:  Eur J Cancer       Date:  1973-07       Impact factor: 9.162

Review 5.  Inhibition of the multiplication of enveloped viruses by glucose derivatives.

Authors:  C Scholtissek
Journal:  Curr Top Microbiol Immunol       Date:  1975       Impact factor: 4.291

6.  A new procedure for the preparation of GDP-[U-14C]mannose.

Authors:  W A Braell; M A Tyo; S S Krag; P W Robbins
Journal:  Anal Biochem       Date:  1976-08       Impact factor: 3.365

7.  Metabolism of 2-deoxy-D glucose by Baker's yeast. IV. Incorporation of 2-deoxy-D-glucose into cell wall mannan.

Authors:  P Biely; Z Krátký; S Bauer
Journal:  Biochim Biophys Acta       Date:  1972-02-11

8.  The deoxyfluoro-D-glucopyranose 6-phosphates and their effect on yeast glucose phosphate isomerase.

Authors:  E M Bessell; P Thomas
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

9.  The effect of substitution at C-2 of D-glucose 6-phosphate on the rate of dehydrogenation by glucose 6-phosphate dehydrogenase (from yeast and from rat liver).

Authors:  E M Bessell; P Thomas
Journal:  Biochem J       Date:  1973-01       Impact factor: 3.857

10.  The use of deoxyfluoro-D-glucopyranoses and related compounds in a study of yeast hexokinase specificity.

Authors:  E M Bessell; A B Foster; J H Westwood
Journal:  Biochem J       Date:  1972-06       Impact factor: 3.857

View more
  2 in total

1.  The role of C-4-substituted mannose analogues in protein glycosylation. Effect of the guanosine diphosphate esters of 4-deoxy-4-fluoro-D-mannose and 4-deoxy-D-mannose on lipid-linked oligosaccharide assembly.

Authors:  W McDowell; T J Grier; J R Rasmussen; R T Schwarz
Journal:  Biochem J       Date:  1987-12-01       Impact factor: 3.857

Review 2.  Inhibitors of protein glycosylation and glycoprotein processing in viral systems.

Authors:  R Datema; S Olofsson; P A Romero
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.